$TLCC
Twinlab Consolidated Holdings Inc

2024 Q3 Form 10-Q Financial Statement

#000175392624001309 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $3.118M
YoY Change -36.09%
Cost Of Revenue $1.892M
YoY Change -53.91%
Gross Profit $1.226M
YoY Change 58.4%
Gross Profit Margin 39.32%
Selling, General & Admin $1.006M
YoY Change -59.94%
% of Gross Profit 82.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K
YoY Change -83.33%
% of Gross Profit 0.16%
Operating Expenses $1.006M
YoY Change -59.94%
Operating Profit $220.0K
YoY Change -112.67%
Interest Expense -$1.970M
YoY Change -189.34%
% of Operating Profit -895.45%
Other Income/Expense, Net -$1.962M
YoY Change -12.72%
Pretax Income -$1.742M
YoY Change -56.29%
Income Tax $6.000K
% Of Pretax Income
Net Earnings -$1.573M
YoY Change -60.59%
Net Earnings / Revenue -50.45%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 259.1M shares 259.1M shares
Diluted Shares Outstanding 259.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $265.0K
YoY Change 86.62%
Cash & Equivalents $265.0K
Short-Term Investments
Other Short-Term Assets $400.0K
YoY Change -57.17%
Inventory $2.394M
Prepaid Expenses
Receivables $1.207M
Other Receivables $0.00
Total Short-Term Assets $4.266M
YoY Change -54.55%
LONG-TERM ASSETS
Property, Plant & Equipment $3.000K
YoY Change -97.0%
Goodwill
YoY Change
Intangibles $120.0K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $1.290M
YoY Change 2.54%
Total Long-Term Assets $3.021M
YoY Change -31.68%
TOTAL ASSETS
Total Short-Term Assets $4.266M
Total Long-Term Assets $3.021M
Total Assets $7.287M
YoY Change -47.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.308M
YoY Change -56.3%
Accrued Expenses $45.97M
YoY Change 15.37%
Deferred Revenue $2.222M
YoY Change 4.56%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $92.90M
YoY Change -2.88%
Total Short-Term Liabilities $148.3M
YoY Change 3.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.712M
YoY Change -43.35%
Total Long-Term Liabilities $1.712M
YoY Change -43.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $148.3M
Total Long-Term Liabilities $1.712M
Total Liabilities $150.0M
YoY Change 2.78%
SHAREHOLDERS EQUITY
Retained Earnings -$373.8M
YoY Change 2.91%
Common Stock $231.6M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $500.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$142.7M
YoY Change
Total Liabilities & Shareholders Equity $7.287M
YoY Change -47.23%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.573M
YoY Change -60.59%
Depreciation, Depletion And Amortization $2.000K
YoY Change -83.33%
Cash From Operating Activities $941.0K
YoY Change 22.85%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -815.0K
YoY Change 12.41%
NET CHANGE
Cash From Operating Activities 941.0K
Cash From Investing Activities
Cash From Financing Activities -815.0K
Net Change In Cash 126.0K
YoY Change 207.32%
FREE CASH FLOW
Cash From Operating Activities $941.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1742000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3991000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2516000 usd
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
dei Entity Central Index Key
EntityCentralIndexKey
0001590695
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55181
dei Entity Registrant Name
EntityRegistrantName
Twinlab Consolidated Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3951742
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 T-Rex Avenue, Suite 225
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
443-4301
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
259092833 shares
CY2024Q2 us-gaap Cash
Cash
265000 usd
CY2023Q4 us-gaap Cash
Cash
19000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1207000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1911000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
2394000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3402000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
400000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
194000 usd
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
161000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4266000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5687000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1608000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1889000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1290000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1290000 usd
CY2024Q2 us-gaap Assets
Assets
7287000 usd
CY2023Q4 us-gaap Assets
Assets
8995000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2308000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2080000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
946000 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1897000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2052000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
43105000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
39851000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
92895000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93637000 usd
CY2024Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
7097000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
7257000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
148269000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
145823000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1712000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2197000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1712000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2197000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
149981000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
148020000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
393898884 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
393898884 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
394000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
394000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231249000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231249000 usd
CY2024Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
134806051 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
134806051 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
500000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
500000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373807000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-370138000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-142694000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-139025000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7287000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8995000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3118000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3058000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5888000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6797000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1892000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1869000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3820000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4130000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
1226000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1189000 usd
us-gaap Gross Profit
GrossProfit
2068000 usd
us-gaap Gross Profit
GrossProfit
2667000 usd
CY2024Q2 us-gaap Selling Expense
SellingExpense
121000 usd
CY2023Q2 us-gaap Selling Expense
SellingExpense
252000 usd
us-gaap Selling Expense
SellingExpense
218000 usd
us-gaap Selling Expense
SellingExpense
591000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
885000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1242000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1812000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2909000 usd
CY2024Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
-324000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
220000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-305000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
38000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-509000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1970000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2205000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3961000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4322000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1962000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2205000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3953000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4292000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2510000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3915000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4801000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1748000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3921000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4801000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
175000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1475000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
251000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1573000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3991000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3670000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6801000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-125311000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2810000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-128121000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3991000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-132112000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-139025000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2096000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-141121000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1573000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-142694000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3670000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6801000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
251000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2000000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3921000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4801000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
281000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
471000 usd
us-gaap Inventory Write Down
InventoryWriteDown
110000 usd
us-gaap Inventory Write Down
InventoryWriteDown
7000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-413000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-534000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
20000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
21000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1117000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-578000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-898000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1375000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-45000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1921000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
224000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1488000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-463000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-413000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3103000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3874000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
988000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1010000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-27000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
961000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1009000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-715000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1735000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-715000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1735000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
246000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-726000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
868000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
265000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142000 usd
us-gaap Interest Paid Net
InterestPaidNet
787000 usd
us-gaap Interest Paid Net
InterestPaidNet
1068000 usd
tlcc Disposal Of Right Of Use Asset At Lease Termination
DisposalOfRightOfUseAssetAtLeaseTermination
0 usd
tlcc Disposal Of Right Of Use Asset At Lease Termination
DisposalOfRightOfUseAssetAtLeaseTermination
608000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;">Note </span><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>1</span></span></span> <span style="font-family: 'Times New Roman'; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;"> Nature of Business </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">Nature of Business</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Twinlab Consolidated Holdings, Inc. (the “Company”, “Twinlab,” “we,” “our” and “us”) was incorporated on </span><span style="font-family: 'Times New Roman'; line-height: inherit;">October 24, 2013 </span><span style="font-family: 'Times New Roman'; line-height: inherit;">under the laws of the State of Nevada as Mirror Me, Inc. On </span><span style="font-family: 'Times New Roman'; line-height: inherit;">August 7, 2014, </span><span style="font-family: 'Times New Roman'; line-height: inherit;">we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">We are an integrated marketer, distributor, and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Our products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name, a market leader in the healthy aging and beauty from within categories sold under the Reserveage Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name; and a full line of herbal teas sold under the Alvita<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">We also performed services between private label distributors and contract manufacturers under the NutraScience Labs (“NSL”) brand name. NSL facilitated the production of new supplements to market and reformulated existing products to include scientifically-backed ingredients. We provided our customers with numerous production services, including manufacturing, testing, label and packaging design, order fulfillment, and regulatory compliance.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">NSL facilitated the contract manufacture of a variety of high-quality vitamin and supplement products, including but </span><span style="font-family: 'Times New Roman'; line-height: inherit;">not</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> limited to, immune support supplements, cognitive support products, prebiotics and probiotics, supplements for weight management, and sports nutrition supplements. Our role in the production of these products was to help our customers manufacture or reformulate dietary supplements for sale and distribution. We did this by working with contract manufacturers to build scientifically backed formulas for resale to our end customers. We also simplified the production process by providing quality control checks, storing inventory on site, labeling and designing finished products, and drop shipping finished products ready for sale to our end customers. We did </span><span style="font-family: 'Times New Roman'; line-height: inherit;">not</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> market these private label products, but rather sold the products to the customer, who was then responsible for the marketing, distribution, and sale to retailers or to their end customers. <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">The services performed under NSL ceased with the abandonment of operations that began in July 2023.</span></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">Going Concern</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. As of </span><span style="font-family: 'Times New Roman'; line-height: inherit;"><span>June 30, 2024</span>, </span><span style="font-family: 'Times New Roman'; line-height: inherit;">we had an accumulated def<span style="line-height: inherit;">icit of $</span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman'; line-height: inherit;">373,807</span></span><span style="font-family: 'Times New Roman'; line-height: inherit;">. <span style="line-height: inherit;">Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs as well as the abandonment of operations of NSL, and interest and refinancing charges associated with our debt.</span> Losses have been funded primarily through debt.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Because of our history of operating losses and significant interest expense on our debt, we have a working capital deficiency of $</span><span style="font-family: 'Times New Roman'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">144,003</span></span><span style="font-family: 'Times New Roman'; line-height: inherit;"> as of <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span>June 30, 2024</span></span></span><span style="font-family: 'Times New Roman'; line-height: inherit;">. </span><span style="font-family: 'Times New Roman'; line-height: inherit;">We also have $</span><span style="font-family: 'Times New Roman'; line-height: inherit;">92,895</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> of debt, presented in current liabilities. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Management is addressing operating issues through the following actions: <span style="line-height: inherit;">focusing on growing the core business and brands; continuing emphasis on major customers and key products; and continuing to negotiate lower prices from major suppliers</span>. </span><span style="font-family: 'Times New Roman'; line-height: inherit;">We will need to raise additional capital through debt, equity or the sale of assets during the current year</span><span style="font-family: 'Times New Roman'; line-height: inherit;">. There can be </span><span style="font-family: 'Times New Roman'; line-height: inherit;">no</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> assurance that sources of funding will be available when needed on acceptable terms or at all. If we cannot obtain additional funding when required, the Company may sell certain assets, enter into collaborations, strategic alliances, merger and acquisition activities, and licensing agreements, negotiate with its principal lenders, wind-up operations of other subsidiaries, or file for bankruptcy protection.</span></p>
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373807000 usd
CY2024Q2 tlcc Working Capital Deficiency
WorkingCapitalDeficiency
144003000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
92895000 usd
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style="margin: 0px; color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.2;"><span style="font-style: italic;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;">Revised Prior Period Financial Statements</span></span></span></p> <p style="margin: 0pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman';"><span style="font-family: 'times new roman'; font-size: 10pt;"> </span></p> <p style="margin: 0px; color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.2; text-indent: 27pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">During the period close for the three months ended March 31, 2024, the Company discovered certain errors related to its accounting policy for the accounting of discontinued operations. The balance sheet did not segregate assets and liabilities for discontinued operations for a subsidiary of the Company on our December 31, 2023 balance sheets that were previously filed. This lack of segregation on the balance sheet did not impact the statements of operations or stockholders' deficit.</span></p> <p style="margin: 0px; color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.2; text-indent: 27pt; text-align: justify;"><br/></p> <p style="margin: 0px; color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.2; text-indent: 27pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The Company has determined that the impact of this balance sheet reclassification is not material to these previously issued balance sheets and as such no restatement was necessary. Correcting prior year financial statements for immaterial errors would not require previously filed reports to be amended. Such a correction may be made the next time the registrant files the prior year financial statements. Correcting the cumulative error in the current year would also be immaterial to the current year. Accordingly, these misstatements were corrected, and the adjustments are reflected in the related periods as noted below. The reclassifications made to the December 31, 2023 balance sheets are summarized below. </span></p> <p style="margin: 0pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman';"><span style="font-family: 'times new roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman';"><span style="font-family: 'times new roman'; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Consolidated Balance Sheets:</span></span></p> <p style="margin: 0pt; color: #000000; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: #ffffff; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'times new roman';"><br/></p> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-right: none; border-left: none;"> <div> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <table cellpadding="0" cellspacing="0" style="height: 128px; border-collapse: collapse; margin: 0px; font-family: 'times new roman'; font-size: 10pt; text-indent: 0px; width: 100%;" width="100%"> <tbody style="margin: 0px; text-indent: 0px;"> <tr style="height: 18px; margin: 0px; text-indent: 0px;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="border-image: initial; padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td colspan="10" style="border-image: initial; padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px; border-bottom-width: 0.75pt; border-bottom-style: solid; border-bottom-color: #000000 !important;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px; text-align: center;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit; font-weight: bold;"> As of December 31, 2023</span><span style="font-family: 'times new roman', times; font-size: 10pt;">  </span></p> </td> <td style="height: 18px;"><br/></td> </tr> <tr style="height: 10px; margin: 0px; text-indent: 0px;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td colspan="2" style="border-image: initial; padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px; border-bottom-width: 0.75pt; border-bottom-style: solid; border-bottom-color: #000000 !important;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px; text-align: center;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold;">Previously Reported</span><br/></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit; font-weight: bold;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit; font-weight: bold;">   </span></p> </td> <td colspan="2" style="border-image: initial; padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px; border-bottom-width: 0.75pt; border-bottom-style: solid; border-bottom-color: #000000 !important;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold;">Adjustments</span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit; font-weight: bold;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit; font-weight: bold;">   </span></p> </td> <td colspan="2" style="border-image: initial; padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: center; height: 10px; border-bottom-width: 0.75pt; border-bottom-style: solid; border-bottom-color: #000000 !important;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-weight: bold;">Revised</span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 18px; margin: 0px; text-indent: 0px; background-color: #cceeff;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 55%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Accounts receivable </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> $ </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px; width: 12%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 2,072 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> $ </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px; width: 12%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> (161 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> ) </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> $ </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; text-align: right; width: 12%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 1,911 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; width: 1%;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 10px; margin: 0px; text-indent: 0px;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Current assets of discontinued operations </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> - </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 161 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"></td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px; text-align: right;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 161 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 10px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 18px; margin: 0px; text-indent: 0px; background-color: #cceeff;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Accounts payable </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 6,803 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> (4,723 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;">)</td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; text-align: right;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 2,080 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 18px; margin: 0px; text-indent: 0px;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Accrued expenses and other current liabilities </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 4,106 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> (2,054 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;">)</td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px; text-align: right;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 2,052 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 18px; margin: 0px; text-indent: 0px; background-color: #cceeff;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Short term lease liabilities </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 1,426 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> (480 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;">)</td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px; text-align: right;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 946 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; background-color: #cceeff; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> </tr> <tr style="height: 18px; margin: 0px; text-indent: 0px;"> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> Current liabilities of discontinued operations </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><br/></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> - </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><br/></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; text-align: right; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 7,257 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"></td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><br/></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px; text-align: right;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><span> 7,257 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; margin: 0px; text-indent: 0px; height: 18px;"> <p style="margin: 0px; text-indent: 0px; padding-left: 0px; padding-right: 0px;"><br/></p> </td> </tr> </tbody> </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-style: italic; font-size: 10pt; line-height: inherit;">Use of Estimates</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts receivable, allowance for credit losses, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill.</span></p>
CY2024Q2 tlcc Contract With Customer Liability Customer Deposits Current
ContractWithCustomerLiabilityCustomerDepositsCurrent
2149000 usd
CY2023Q4 tlcc Contract With Customer Liability Customer Deposits Current
ContractWithCustomerLiabilityCustomerDepositsCurrent
2022000 usd
CY2024Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
73000 usd
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
127000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2222000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2149000 usd
CY2024Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
449000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43000 usd
CY2024Q2 tlcc Accounts Receivable Allowance For Expected Credit Loss Current
AccountsReceivableAllowanceForExpectedCreditLossCurrent
406000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
862000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
175000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1748000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2516000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3921000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4801000 usd
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
175000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1475000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
251000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1573000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3670000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6801000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-style: italic; font-size: 10pt; line-height: inherit;">Significant Concentration of Credit Risk</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 6pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman'; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;">Sales to our top <span style="border-left: none; border-right: none; line-height: inherit;">three</span> customers aggregated to approximately </span><span style="line-height: inherit;"><span style="line-height: inherit;">55</span>% and <span style="line-height: inherit;">32</span>% of total sales for the <span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><span>three months ended June 30, 2024</span></span></span></span> and <span>2023</span>,</span><span style="line-height: inherit;"><span style="line-height: inherit;"> <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">respectively, and 55% and 25% of total sales for the <span>six months ended June 30, 2024</span> and <span>2023</span>, respectively. </span></span></span><span style="line-height: inherit;">Sales to <span style="line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">one</span></span> of those customers were approximately <span style="line-height: inherit;">33</span>% and <span style="line-height: inherit;">9</span>% of total sales for the <span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>three months ended June 30, 2024</span></span></span></span> and <span style="border-left: none; border-right: none; line-height: inherit;"><span>2023</span></span>,<span style="line-height: inherit;"> respectively, and 30% and 9% of total sales for the <span>six months ended June 30, 2024</span> and <span>2023</span>, respectively. </span>Accounts receivable from these <span style="line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">three</span></span> customers were approximately <span style="line-height: inherit;">77</span>% and <span style="line-height: inherit;">42</span>% <span style="text-indent: 27pt; line-height: inherit;">of total accounts receivable as of </span><span style="text-indent: 27pt; line-height: inherit;"><span>June 30, 2024</span> </span><span style="text-indent: 27pt; line-height: inherit;">and </span><span style="text-indent: 27pt; line-height: inherit;"><span>December 31, 2023</span>, </span><span style="text-indent: 27pt; line-height: inherit;">respectively.</span> </span></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman';"><br/></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman'; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="text-indent: 27pt; line-height: inherit;">A <span style="border-left: none; border-right: none; line-height: inherit;"><span>single</span></span> customer represents </span><span style="text-indent: 27pt; line-height: inherit;">0</span><span style="text-indent: 27pt; line-height: inherit;">% and </span><span style="text-indent: 27pt; line-height: inherit;">3</span><span style="text-indent: 27pt; line-height: inherit;">% of total accounts receivable as of </span><span style="text-indent: 27pt; line-height: inherit;"><span>June 30, 2024</span> </span><span style="text-indent: 27pt; line-height: inherit;">and </span><span style="text-indent: 27pt; line-height: inherit;"><span>December 31, 2023</span></span><span style="text-indent: 27pt; line-height: inherit;">, </span><span style="text-indent: 27pt; line-height: inherit;">respectively. This customer is a related party through a director who sits on both the Company’s board of directors and that of the customer.</span></span></p>
CY2024Q2 us-gaap Depreciation
Depreciation
2000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
12000 usd
us-gaap Depreciation
Depreciation
6000 usd
us-gaap Depreciation
Depreciation
24000 usd
CY2024Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
120000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
120000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10882000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10882000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10762000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10762000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q2 tlcc Long Term Debt From Continuing Operations
LongTermDebtFromContinuingOperations
92895000 usd
CY2023Q4 tlcc Long Term Debt From Continuing Operations
LongTermDebtFromContinuingOperations
93637000 usd
tlcc Repayment Of Senior Credit Facility With Midcap From Discontinued Operations
RepaymentOfSeniorCreditFacilityWithMidcapFromDiscontinuedOperations
-27000 usd
CY2023 tlcc Repayment Of Senior Credit Facility With Midcap From Discontinued Operations
RepaymentOfSeniorCreditFacilityWithMidcapFromDiscontinuedOperations
0 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
92922000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
93637000 usd
CY2024Q2 tlcc Long Term Debt Current Maturities
LongTermDebtCurrentMaturities
92922000 usd
CY2023Q4 tlcc Long Term Debt Current Maturities
LongTermDebtCurrentMaturities
93637000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4500000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
tlcc Class Of Warrant Or Right Granted During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Granted During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodExercisePriceOfWarrantsOrRights
0
tlcc Class Of Warrant Or Right Cancelled During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Canceled During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCanceledDuringPeriodExercisePriceOfWarrantsOrRights
0
tlcc Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Exercised During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodExercisePriceOfWarrantsOrRights
0
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4500000 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2024Q2 us-gaap Lease Cost
LeaseCost
178000 usd
us-gaap Lease Cost
LeaseCost
424000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
106000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
99000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
580000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1136000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
952000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
306000 usd
CY2024Q2 tlcc Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2974000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
295000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2679000 usd
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
167000 usd
us-gaap Sublease Income
SubleaseIncome
334000 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
292000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
581000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0825 pure
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0825 pure
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
1528384 shares
CY2024Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2024Q2 tlcc Subscription Receivable Annual Interest Rate
SubscriptionReceivableAnnualInterestRate
0.05 pure

Files In Submission

Name View Source Status
0001753926-24-001309-index-headers.html Edgar Link pending
0001753926-24-001309-index.html Edgar Link pending
0001753926-24-001309.txt Edgar Link pending
0001753926-24-001309-xbrl.zip Edgar Link pending
ex311_1.htm Edgar Link pending
ex321_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tlcc-20240630_def.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlcc-20240630.htm Edgar Link pending
tlcc-20240630.xsd Edgar Link pending
tlcc-20240630_cal.xml Edgar Link unprocessable
tlcc-20240630_lab.xml Edgar Link unprocessable
tlcc-20240630_pre.xml Edgar Link unprocessable
tlcc-20240630_htm.xml Edgar Link completed